• Title of article

    Trans-4-methyl-3-imidazoyl pyrrolidine as a potent, highly selective histamine H3 receptor agonist in vivo

  • Author/Authors

    Neng-Yang Shih، نويسنده , , Robert Aslanian، نويسنده , , Andrew T. Lupo Jr.، نويسنده , , Steve Orlando، نويسنده , , John J. Piwinski، نويسنده , , Michael J. Green، نويسنده , , Ashit K. Ganguly، نويسنده , , Robert West، نويسنده , , Salvatore Tozzi، نويسنده , , William Kreutner، نويسنده , , John A. Hey، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 1998
  • Pages
    6
  • From page
    243
  • To page
    248
  • Abstract
    Extensive structural modification of immepyr (+)-2 led to the discovery of trans-4-methyl-3-imidazoyl pyrrolidine (±)-3a as a potent and highly selective H3 agonist. The pyrroline (±)-3a was resolved, and its (+) enantiomer, Sch 50971 [(+)-3a], showed a greater separation of H3 and H1 activities in vivo (H3/H1 ratio 330) than (R)-α-methylhistamine (+)-1 (H3/H1 RATIO = 17), the standard H3 agonist.
  • Journal title
    Bioorganic & Medicinal Chemistry Letters
  • Serial Year
    1998
  • Journal title
    Bioorganic & Medicinal Chemistry Letters
  • Record number

    789218